A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults.
about
Pharmacotherapies for cannabis dependenceWHY NOT POT?: A Review of the Brain-based Risks of CannabisProgress toward pharmacotherapies for cannabis-use disorder: an evidence-based reviewSleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive reviewAdvances in Medications and Tailoring Treatment for Alcohol Use DisorderCannabinoid abuse and addiction: Clinical and preclinical findingsPregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive ReviewThe cannabis withdrawal syndrome: current insightsA Review of Magnetic Resonance Spectroscopy Studies in Marijuana using Adolescents and Adults.α2δ-1 signaling in nucleus accumbens is necessary for cocaine-induced relapse.Youth marijuana use: state of the science for the practicing clinician.New Developments in Understanding and Treating Adolescent Marijuana DependenceMisuse and abuse of pregabalin and gabapentin: cause for concern?Open-label pilot study of quetiapine treatment for cannabis dependence.Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR?ASPIRE Model for Treating Cannabis and Other Substance Use Disorders: A Novel Personalized-Medicine FrameworkNeeded Relapse-Prevention Research on Novel Framework (ASPIRE Model) for Substance Use Disorders Treatment.Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial.γ-Amino butyric acid and glutamate abnormalities in adolescent chronic marijuana smokers.Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment: A Prospective StudySeparate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocannabinol in humans discriminating [INCREMENT]9-tetrahydrocannabinolEffects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differencesEffects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings.Treatment of Cannabis Use Disorder: Current Science and Future Outlook.Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol.Pilot trial of gabapentin for the treatment of benzodiazepine abuse or dependence in methadone maintenance patients.Screening Medications for the Treatment of Cannabis Use Disorder.Emerging Pharmacologic Treatments for Adolescent Substance Use: Challenges and New Directions.Evidence-based Treatment Options in Cannabis Dependency.Gabapentin treatment for alcohol dependence: a randomized clinical trial.Orexin/hypocretin based pharmacotherapies for the treatment of addiction: DORA or SORA?Novel Pharmacologic Approaches to Treating Cannabis Use Disorder.Clinical neuroscience of addiction: similarities and differences between alcohol and other drugs.Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure.Clinical Approach to the Heavy Cannabis User in the Age of Medical Marijuana.Human Drug Discrimination: Elucidating the Neuropharmacology of Commonly Abused Illicit Drugs.Are Alcohol Anti-relapsing and Alcohol Withdrawal Drugs Useful in Cannabinoid Users?The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use DisordersSativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series.
P2860
Q24187250-D794276C-B7C1-4168-AC78-B91AFA6BC5EAQ26746122-DFC581AC-7725-4F2D-B835-2C7E15D75261Q26746192-5CEF4AE7-388D-4C89-8D13-0F0357657345Q26749602-B0861A3D-23EB-48DC-BF74-333A5FD20C09Q26799814-8E69D4E9-3D00-4C5B-AE5C-C35F758D4A89Q26851944-4FB72301-5E86-421D-87A5-925E01CCAF1AQ28074617-C2482C8F-ABEA-4EEB-AABE-60D12B5E10ADQ30313180-B669372B-3B78-4FD7-8377-1A625A0D19E8Q30768975-7E1C755C-55C8-48AD-A8C7-309898EAA4A5Q33770434-B4328BC2-DAF0-483E-A34C-A197134A1A32Q34069074-D47E1BC6-0585-408A-8C2B-93D533263AFEQ34288989-EF804C3E-C10D-4CF3-8883-D8568A967CABQ34416866-72B83697-4555-448D-B29B-0BC95748AAE0Q34512547-21AF8DE9-2646-4E70-861B-E9789EC5EAB4Q34613783-EF67EFC4-4961-4832-A817-6804464680A7Q34615910-5B43F0B0-DC8A-4B08-8817-D12769867C12Q34650909-E603E024-C32F-46BA-B152-DD027F3F6B7DQ35153407-BEB87275-D046-4BEF-8526-40FB7AF58FF4Q36249079-18E1F353-57B7-41A5-AF57-B7ECF6D00668Q36295861-A13DA52F-446E-494A-9462-B20BB10BAEF2Q36567126-9DA1F6BC-9BDF-459F-B933-A07B743076D9Q36624486-DF59C4CE-BD82-4626-8562-1845007A0753Q36672926-DD41E5C3-0F22-4FD7-8BCF-138B6032CB5CQ36932158-8D66FE01-F6EB-43F7-92DD-0DCAC1D006CFQ36936298-AF28D9ED-BE2F-4C17-9CD6-7A1682F7CAF1Q37107238-6E7FDFA3-8164-42DC-B2A5-DD92E38D6A11Q37141499-CBA23A6A-2890-4F89-A0BC-58030F8E3C21Q37187618-C1CF5215-05B3-44E6-A2B0-A85EFF5353C2Q37200944-7BA91D09-778F-4868-AFD7-01D86D5DCB75Q37396986-70DA3DE8-77D0-4B48-A6DF-AD99F807C541Q37577544-214A6336-F97D-482D-9552-5B5463FFA04CQ38221344-B843BA60-9C24-4E83-89E1-91B536523383Q38222436-1E31B7AE-FCB0-4F7E-8F9B-A4A9B73588DAQ38594528-F97AED79-2B8A-45FA-8764-01DE7122C366Q38636791-31B4AD40-D0C5-4041-BAB4-404E7365C68AQ38735357-F3ED153D-32A0-4E6F-8AA4-423C1C0E1A73Q38856900-CA9B5A1C-3D0F-4B64-B742-B2EBED22BF8EQ38916400-1816FEB1-8469-4500-86A7-01747EAF7FF9Q38950639-6525E05C-30D9-4DA7-99EB-E822ED09A191Q40719201-4A4736D4-8ADF-4095-AB09-B8A10F3FBAD0
P2860
A proof-of-concept randomized controlled study of gabapentin: effects on cannabis use, withdrawal and executive function deficits in cannabis-dependent adults.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A proof-of-concept randomized ...... in cannabis-dependent adults.
@ast
A proof-of-concept randomized ...... in cannabis-dependent adults.
@en
type
label
A proof-of-concept randomized ...... in cannabis-dependent adults.
@ast
A proof-of-concept randomized ...... in cannabis-dependent adults.
@en
prefLabel
A proof-of-concept randomized ...... in cannabis-dependent adults.
@ast
A proof-of-concept randomized ...... in cannabis-dependent adults.
@en
P2093
P2860
P356
P1476
A proof-of-concept randomized ...... in cannabis-dependent adults.
@en
P2093
Adnan Begovic
Barbara J Mason
Farhad Shadan
John M Light
Kimberly Buffkins
Murali Adusumalli
Rebecca Crean
Santosh Rao
Susan Quello
P2860
P2888
P304
P356
10.1038/NPP.2012.14
P407
P577
2012-02-29T00:00:00Z